Related by context. All words. (Click for frequent words.) 83 Improves Survival 83 Survival Benefit 82 Pooled Analysis 82 Lung Cancer Patients 82 Gastric Cancer 82 Rheumatoid Arthritis Patients 82 Metastatic Prostate Cancer 82 Improves Outcomes 81 Antitumor Activity 81 Advanced Melanoma 81 Patients Treated With 81 Lung Cancer Survival 81 Advanced Colorectal Cancer 81 Prolongs Survival 80 Previously Treated 80 Patients Receiving 80 Hormone Refractory Prostate Cancer 80 Improved Survival 80 Prostate Cancer Patients 80 Unfractionated Heparin 80 Ovarian Cancer Patients 80 Elderly Patients 80 Meets Primary Endpoint 80 Advanced Prostate Cancer 80 Myeloma Patients 80 Breast Cancer Recurrence 80 Stomach Cancer 80 Slow Progression 80 Adjuvant Treatment 80 Adjuvant Chemotherapy 79 HER2 Positive Breast Cancer 79 Combination Treatment 79 Relapsed Refractory 79 Patients Treated 79 Newly Diagnosed Multiple Myeloma 79 Improve Survival 79 Relapsed Multiple Myeloma 79 Overactive Bladder 79 Colorectal Cancer Patients 79 Disease Progression 79 Lowers Risk 79 Appears Safe 79 Patients Undergoing 79 Drug Prevents 79 Shows Promising 79 Heart Failure Patients 79 Brain Metastases 79 Drug Combo 79 Hypertensive Patients 79 Gene Mutation 79 Myelodysplastic Syndromes 79 Node Positive 78 Clinical Trial Results 78 Proves Effective 78 HER2 Positive 78 Relapsing Multiple Sclerosis 78 Invasive Breast Cancer 78 Metastatic Colorectal Cancer 78 Fewer Side Effects 78 Clinical Outcome 78 Investigational Agent 78 Statistically Significant 78 Hepatocellular Carcinoma 78 Breast Tumors 78 Aggressive Prostate Cancer 78 Study Evaluating 78 Breast Cancer Patients 78 Cholesterol Lowering Drug 78 Malignant Melanoma 78 Renal Cancer 78 Multiple Myeloma Patients 78 Breast Cancer Treatment 78 Artery Disease 78 Radical Prostatectomy 78 Osteoporosis Drug 78 Subgroup Analysis 78 Inhaled Corticosteroids 77 Mouse Model 77 Obese Patients 77 Gene Linked 77 Oral Fingolimod 77 Chronic Lymphocytic Leukemia 77 Previously Untreated 77 Follicular Lymphoma 77 Kidney Transplant Patients 77 Resistant Hypertension 77 Drug Candidate 77 Adjuvant Therapy 77 Liver Failure 77 Phase 2b Clinical Trial 77 Treatment Reduces 77 Breast Cancers 77 Fracture Risk 77 Soft Tissue Sarcoma 77 Hormone Receptor Positive 77 Study Showed 77 Prostate Cancer Treatment 77 Increased Mortality 77 Combo Therapy 77 Drug Shows Promise 77 Knee Osteoarthritis 77 Benign Prostatic Hyperplasia 77 Androgen Deprivation Therapy 77 Drug Resistant 77 Postmenopausal Women 77 Significantly Reduced 77 Phase III Clinical Trial 77 Carotid Stenting 77 Genes Linked 77 Long Term Survival 77 Lupus Drug 77 Pediatric Patients 77 Newly Diagnosed 77 Metastatic Renal Cell Carcinoma 77 Anti Tumor Activity 77 Genes Predict 77 Advanced Renal Cell 77 Genetic Variant 77 Phase III Trial 77 Chronic Hepatitis C 77 Lung Cancer Drug 77 Kidney Function 77 Patients Suffering 77 Enlarged Prostate 77 Reduced Risk 76 Osteoporosis Drugs 76 Endometrial Cancer 76 Randomized Study 76 Advanced Ovarian Cancer 76 Lupus Nephritis 76 Investigational Drug 76 Ischemic Stroke 76 Rheumatoid Arthritis Drug 76 Cancer Recurrence 76 Castration Resistant Prostate Cancer 76 Venous Thromboembolism 76 Predict Risk 76 Lung Cancers 76 Treatment Shows Promise 76 Complicated Skin 76 Bone Metastases 76 Naive Patients 76 Premenopausal Women 76 FDA Okays 76 Treated Patients 76 Treating Chronic 76 Potentially Fatal 76 Shows Efficacy 76 Inflammatory Markers 76 Boosts Survival 76 Breast Cancer Cells 76 Anthracycline 76 Phase 2b Study 76 Investigational Compound 76 Phase IIb Trial 76 Cutaneous T 76 Cardiovascular Events 76 Diabetic Patients 76 Migraine Headaches 76 Gene Mutations 76 Bladder Cancer 76 Gout Drug 76 Localized Prostate Cancer 76 Treatment Naive Patients 76 Investigational Treatment 76 Rectal Cancer 76 Anti Tumor 76 Gene Variation 76 Relapsing Remitting Multiple Sclerosis 76 Immune Responses 76 Efficacy Trial 76 Phase III Trials 76 Chronic Sinusitis 76 Controlled Trial 76 Blood Pressure Drug 76 Pulmonary Arterial Hypertension 76 Shows Promise Against 76 Fungal Infections 75 Prolongs Life 75 Tumor Growth 75 Epilepsy Drug 75 Pre Cancerous 75 Long Term Efficacy 75 Chronic Hepatitis B 75 Patient Enrollment 75 Long Term Outcomes 75 Severe Sepsis 75 Stem Cell Treatment 75 Bone Marrow Cells 75 Chronic Myeloid Leukemia 75 Unresectable 75 Prospective Randomized 75 Monotherapy 75 Dose Escalation 75 Gene Variant 75 Significantly Improved 75 Shown Effective 75 Certain Cancers 75 Commonly Used 75 Novel Oral 75 Slows Progression 75 Insulin Resistance 75 Neoadjuvant Chemotherapy 75 Multicenter Trial 75 Obesity Linked 75 Malignant Glioma 75 Demonstrates Positive 75 Demonstrated Significant 75 Preclinical Study 75 Predict Response 75 Lung Tumors 75 Combination REOLYSIN R 75 Refractory Hodgkin Lymphoma 75 ACE Inhibitors 75 Effectively Treats 75 Renal Impairment 75 Plus Ribavirin 75 Is Well Tolerated 75 Beneficial Effects 75 Combination Therapy 75 Therapy Improves 75 Randomized Phase II 75 Gastrointestinal Stromal Tumors 75 Preclinical Data 75 Statin Therapy 75 Autologous Stem Cell Transplantation 75 Therapeutic Potential 75 Osteoporosis Treatment 75 Minimally Invasive Treatment 75 Diabetic Nephropathy 75 Liver Tumors 75 Menopausal Women 75 Low Dose 75 Erectile Dysfunction Drug 75 Serious Infections 75 Predict Breast Cancer 75 Inhibits 75 Epidermal Growth Factor Receptor 75 Bare Metal Stents 75 Novel Mechanism 75 Septic Shock 75 Anticancer Activity 75 Cocaine Addiction 74 Metastatic Melanoma 74 Hepatitis C Virus 74 FDA Approves Drug 74 Well Tolerated 74 Randomized Double Blind 74 Chemoradiation 74 Single Dose 74 Prostate Cancer Vaccine 74 Statin Drugs 74 Demonstrates Efficacy 74 Sustained Efficacy 74 Critically Ill Patients 74 Carcinomas 74 Targeted Therapies 74 Anticancer Drug 74 Genetic Mutation 74 Non Invasive Treatment 74 Spinal Fractures 74 Secondary Hyperparathyroidism 74 Prophylactic Treatment 74 Immune Cells 74 Neovascular Age Related Macular 74 Phase 2a Clinical Trial 74 Cancer Cells 74 Preterm Delivery 74 Recurrent Breast Cancer 74 Premature Infants 74 Iron Overload 74 Skin Cancers 74 Cardiotoxicity 74 Prostate Tumors 74 Hepatitis C Patients 74 JAK Inhibitor 74 Cholesterol Levels 74 Experimental Vaccine 74 Leukemias 74 Allergic Rhinitis 74 Improve Outcomes 74 Less Invasive 74 Cholesterol Drugs 74 Levels Linked 74 Epilepsy Drugs 74 Effective Than 74 Therapeutic Efficacy 74 Orally Active 74 Novel Antibiotic 74 Peginterferon Alfa 2b 74 Randomized Trials 74 Transplant Patients 74 Often Misdiagnosed 74 Gum Disease 74 Hematological Cancers 74 Sipuleucel T 74 Transdermal Patch 74 Breast Density 74 Decitabine 74 Kidney Transplants 74 Solid Tumors 74 Postmenopausal Osteoporosis 74 Antiangiogenic 74 Acute Pancreatitis 74 Phase 2b Trial 74 Study Shows Promise 74 Oral Anticoagulant 74 Cell Transplants 74 Drug Fails 74 Squamous Cell Carcinoma 74 Breast Cancer Metastasis 74 Effective Treatments 74 Acute Ischemic Stroke 74 Liver Metastases 74 Completes Patient Enrollment 74 II Clinical Trial 74 Survival Rates 74 Intracerebral Hemorrhage 74 Demonstrates Potent 74 Anticancer Drugs 74 Signaling Pathway 74 Proven Effective 74 Esophageal Cancer 74 Metastatic Pancreatic Cancer 74 Stent Restenosis 74 Autoimmune Disorders 74 Tumor Cells 74 Nilotinib 74 Treatment Resistant 74 Blood Clots 74 Demonstrates Significant 74 Radiofrequency Ablation 74 Chemotherapy Regimen 74 Data Suggest 74 Autoimmune Disease 74 Sleep Disturbances 74 Pegylated Interferon 74 Lung Cancer Trial 74 Treatment Naive 74 Peginterferon Alfa 2a 74 Contrast Agents 74 Cell Lymphoma 74 FDA Approvals 74 Novel Treatments 74 Trial Evaluating 74 Sustained Reduction 74 Treatment Experienced 73 Cholesterol Drug 73 Randomized Phase 73 Urinary Incontinence 73 Versus Placebo 73 Neoadjuvant 73 Atypical Antipsychotics 73 Prostate Cancer Recurrence 73 Pharmacokinetic Study 73 Protein Linked 73 Polymerase Inhibitor 73 Pivotal Phase III 73 Cancer Treatments 73 Bevacizumab 73 Paclitaxel Carboplatin 73 Peginterferon 73 Nymox NX 73 Acute Heart Failure 73 Rotavirus Vaccine 73 Progenitor Cells 73 Meta Analysis 73 Nicotine Vaccine 73 Phase 2a Trial 73 Tyrosine Kinase Inhibitor 73 Prostate Cancer Survival 73 Skin Lesions 73 Blood Vessels 73 Colorectal Cancers 73 Physical Function 73 Glatiramer Acetate 73 Stem Cell Transplants 73 Drug Coated Stents 73 Ovarian Cancers 73 Blood Thinner 73 Genes Associated 73 Pivotal Phase 73 Placebo Controlled Trial 73 Successfully Treated 73 Skeletal Muscle 73 Myocardial Ischemia 73 Therapy Reduces 73 Higher Doses 73 Non Inferiority 73 Left Ventricular 73 Receives Orphan Drug Designation 73 Endothelial Function 73 Insulin Glargine 73 Genetic Markers 73 Test Detects 73 Genetic Variation 73 Kidney Transplant Recipients 73 Hormone Therapy 73 Blood Clot Risk 73 Anti Clotting Drug 73 Phase IIb Clinical Trial 73 Partial Onset Seizures 73 Genetic Disorder 73 Bone Fractures 73 Kidney Failure 73 Cognitive Decline 73 Immunosuppression 73 Double Blind Placebo 73 Liver Injury 73 Efficacious 73 Cardiac Function 73 Chronic Heart Failure 73 ST Elevation Myocardial 73 Lymph Node 73 Emerging Therapies 73 Prognostic Factors 73 Controlled Study 73 Beta Blockers 73 Increases Risk 73 Renal Function 73 Increased Risk 73 Liver Damage 73 Chronic Cough 73 Bivalirudin 73 Bone Fracture 73 Lymph Nodes 73 Prostate Cancer Progression 73 Treatment Naïve Patients 73 Drug Eluting 73 Fat Cells 73 Precancerous 73 Newly Diagnosed Patients 73 Minimally Invasive Procedure 73 Bone Marrow Transplants 73 Placebo Controlled Study 73 Treatment Naïve 73 Colorectal Adenomas 73 Antidepressants Linked 73 Reduces Pain 73 Viral Suppression 73 Adenoma 73 Anemia Drug 73 Ovarian Cancer Risk 73 Pivotal Study 73 Shows Promise 73 Renal Tumors 73 Genetic Variations 73 Insulin Sensitivity 73 Diabetic Neuropathy 73 Intracranial Aneurysms 73 Prognostic Significance 72 Coronary Arteries 72 RNAi Therapeutic 72 Treat Heart Failure 72 Colorectal Cancer Risk 72 Ovarian Cancer Treatment 72 Migraine Drug 72 Diffuse Large B 72 Brain Scans 72 Thyroid Hormone 72 Breast Cancer Stem Cells 72 Cognitive Function 72 Fixed Dose 72 Novel Therapeutic 72 Hormone Replacement 72 Cognitive Impairment 72 Male Contraceptive 72 Thromboembolism 72 Kinase Inhibitor 72 Ischemic 72 Ovary Removal 72 HCV Protease Inhibitor 72 Iron Deficiency 72 Predict Prostate Cancer 72 Antiviral Drugs 72 Radiofrequency Ablation RFA 72 Reduces Mortality 72 Treatment Regimen 72 Cholesterol Lowering Drugs 72 Brain Atrophy 72 Tolerability 72 Infected Patients 72 Peptic Ulcer 72 Patient Outcomes 72 Multicenter Randomized 72 Oral Mucositis 72 Kidney Stones 72 Post Operative 72 Allogeneic 72 Spinal Fusion 72 Testosterone Patch 72 Genetic Mutations 72 Study Demonstrates 72 ORLive Presents 72 Excessive Sweating 72 Lung Cancer Treatment 72 Hsp# Inhibitor 72 Subtypes 72 Blood Pressure Drugs 72 Dendritic Cells 72 Lung Cancer Risk 72 Atypical Hemolytic Uremic Syndrome 72 Prevent Breast Cancer 72 Clinical Trial Evaluating 72 Initiate Phase III 72 Laryngeal Cancer 72 Schizophrenia Drug 72 Severe Asthma 72 Virus Infection 72 Blocked Arteries 72 Cardiovascular Outcomes 72 Venous Thrombosis 72 Tumor Response 72 Chemotherapy Improves 72 Chronic HCV 72 Virus Linked 72 Antitumor 72 Heartburn Drugs 72 Bosutinib 72 Pivotal Trial 72 Arthritis Drug 72 Granted Orphan Drug 72 Prostate Biopsy 72 Organ Rejection 72 Gastric Ulcers 72 Breast Cancer Tumors 72 Antipsychotic Drugs 72 Malignancy 72 Colon Polyps 72 Inflammatory Disease 72 Metastases 72 Androgen Deprivation 72 NICE Recommends 72 Prognostic Value 72 Completes Enrollment 72 Achieves Primary Endpoint 72 First Patient Enrolled 72 Acute Myocardial Infarction 72 Demonstrates Potential 72 Hepatitis C Treatment 72 Treatable 72 Carboplatin Paclitaxel 72 Suicidality 72 Adjunctive Therapy 72 Stent Thrombosis 72 Antifungals 72 See CLINICAL PHARMACOLOGY 72 Demonstrates Sustained 72 Asthma Treatment 72 Prostate Cancer Risk 72 Interferon Beta 72 Analytical Tool 72 Obese Teens 72 Renal Artery 72 Left Ventricular Hypertrophy 72 Diabetic Kidney Disease 72 Clinically Tested 72 Relapsed Refractory Multiple Myeloma 72 Present Preclinical Data 72 Psoriasis Patients 72 NDA Submission 72 Clostridium difficile Infection 72 Protease Inhibitors 72 Renal Cell Cancer 72 Hepatitis C Genotype 72 Neuroprotective Effects 72 Kinase Inhibitors 72 Therapy Shows Promise 72 Panic Disorder 72 TNF Blockers 72 Osteoarthritis Patients 72 Adefovir 71 Shingles Vaccine 71 Being Studied 71 Inhaled Nitric Oxide 71 Mimetics 71 Protein Involved 71 Fluorouracil 71 Novel Inhibitor 71 Randomized Controlled Trials 71 Study Casts Doubt 71 Chronic Inflammation 71 Significantly Improves 71 Phase 1b Clinical Trial 71 Fondaparinux 71 Advanced Pancreatic Cancer 71 Circulating Tumor Cells 71 Elevated Levels 71 Treating Heart Failure 71 Beta Blocker 71 Hemodialysis Patients 71 Reduces Risk 71 Lower Blood Pressure 71 Brentuximab Vedotin SGN 71 Diabetic Foot Ulcer 71 Initiates Clinical Trial 71 Zoledronic Acid 71 Induces 71 Contrast Agent 71 Molecular Diagnostic Test 71 Atopic Dermatitis 71 Capecitabine 71 Statins Reduce 71 Bacterial Infection 71 Poorly Controlled 71 Initiate Clinical Trial 71 Gene Therapy Trial 71 Leukemia Cells 71 Chronic Constipation 71 Childhood Leukemia 71 Commonly Prescribed 71 Abiraterone Acetate 71 Cardiovascular Disease Risk 71 Hematopoietic Stem Cell Transplantation 71 Balloon Angioplasty 71 Liver Cancer 71 Randomized Double blind 71 Endothelial Cells 71 Glycemic Control 71 Phase IIa Clinical Trial 71 Estrogen Therapy 71 Thrombotic 71 Non Alcoholic Fatty 71 Diabetic Foot Ulcers 71 Node Negative 71 Moderate Drinking 71 Postherpetic Neuralgia 71 Immune Cell 71 Acute Coronary Syndromes 71 Inflammatory Diseases 71 Gene Mutation Linked 71 Vertebral Compression Fractures 71 Premature Aging 71 Intra Arterial 71 Asthma Symptoms 71 Blood Vessel 71 Sirolimus Eluting Stent 71 Pegylated 71 Fibromyalgia Pain 71 Myelofibrosis 71 Systemic Delivery 71 Back Pain Sufferers 71 Diuretic 71 Menopausal Symptoms 71 Showed Significant 71 Breast Carcinoma 71 Pivotal Clinical Trial 71 Lipid Levels 71 Drug Resistant TB 71 Nerve Cells 71 Tumor Targeting 71 Randomized Controlled Trial 71 Antigen Specific 71 Infarct 71 Oral Formulation 71 Treating Depression 71 Cognitive Deficits 71 Renal Anemia 71 Sirolimus Eluting 71 Postmenopausal 71 Hypercholesterolemia 71 Antidepressant Use 71 Thyroid Cancer 71 Teva Provides Update 71 Metastatic Cancer 71 Chemotherapeutic Agents 71 Recombinant Human 71 Basal Cell 71 Genes Identified 71 Reperfusion Injury 71 Angiogenic 71 Prove Effective 71 Help Predict 71 Epileptic Seizures 71 Smoking Linked 71 B Cell Lymphoma 71 ST Segment Elevation 71 Aurora Kinase 71 Platelet Inhibition 71 Cholesterol Lowering 71 Stem Cell Procedure 71 Disease Modifying 71 Hip Fractures 71 Cancer Patients Treated 71 Attenuates 71 Significantly Reduces 71 Prostatic 71 Clinical Efficacy 71 Patients Enrolled 71 Lowers Blood Pressure 71 CYT# potent vascular disrupting 71 Knee Arthritis 71 Hemorrhagic Stroke 71 Novel Method 71 Functional Outcomes 71 Viral Infections 71 Genetic Defect 71 Desvenlafaxine Succinate 71 Stem Cells Used 71 Coronary Artery Bypass Graft 71 Protease Inhibitor 71 Physician Insights 71 Bacterial Infections 71 Coronary Artery 71 Cardiogenic Shock 71 Watchful Waiting 71 Significant Reduction 71 Stent Implantation 71 Metastatic 71 Glufosfamide 71 Pregnancy Complication 71 Stereotactic Body Radiation Therapy 71 Cardiovascular Mortality 71 Viral Infection 71 Uterine Cancer 71 Genetic Variants 71 Prostate Surgery 71 Safinamide 71 Acne Scars 71 Newly Diagnosed Breast Cancer 71 Initiates Phase III 71 Hyperlipidemia 71 Placebo Effect 71 Strongly Linked 71 Prostate Cancers 71 Nerve Pain 71 Monoclonal Antibodies 71 Hepatitis B Vaccine 71 Vaccine Candidate 71 Bortezomib 71 FDA Panel Recommends 71 Vaccine Protects Against 71 Vaginal Gel 71 Chronic Stress 71 Radiation Dose 70 Brain Tumor Patients 70 Viral Load 70 Mylan Receives Approval 70 Hepatitis B Virus 70 FDA Accepts 70 Randomized Double Blind Placebo 70 Pulmonary Artery 70 Psoriasis Drug 70 Non Responders 70 Metastatic Disease 70 Liver Toxicity 70 Breast Tissue 70 Telaprevir VX 70 Prostate Cancer Surgery 70 Hematological Malignancies 70 Regimens 70 Paraplatin ® 70 Breast Cancer Survival 70 Epoetin Alfa 70 Antibiotic Use 70 Transplant Rejection 70 Depressive Symptoms 70 Cyclooxygenase 2 70 Blood Cancers 70 Preclinical Models 70 Radiation Induced 70 Suicidal Thoughts 70 Embolization 70 Relapsed Refractory Aggressive 70 Early Diagnosis 70 Neoplasms 70 Total Knee Arthroplasty 70 Gastrointestinal Disorders 70 Dose Finding 70 Electrical Stimulation 70 Recurrent Stroke 70 Dasatinib 70 Randomised Trial 70 Tyrosine Kinase Inhibitors 70 Gene Variants 70 Erlotinib 70 Tumor Progression 70 Blood Flow 70 Factor Receptor 70 Novel Peptide 70 Anal Cancer 70 Novel Therapies 70 Immunomodulatory 70 Tumor Cell 70 Prevent Stroke 70 Eculizumab 70 Arterial Disease 70 Urine Test 70 Pegylated Liposomal Doxorubicin 70 Tiotropium 70 Submits NDA 70 Bipolar Mania 70 Diabetic Neuropathic Pain 70 Lung Transplants 70 Heart Stents 70 Symptom Relief 70 Testosterone Levels 70 Targeted Therapy 70 Primary Endpoint 70 Surgical Treatment 70 Regenerative Cells 70 RNAi Therapeutics 70 Antiplatelet 70 Uterine Fibroid Embolization 70 Cancer Therapies 70 REMINDER ORLive Presents 70 Genetic Tests 70 Drug Combinations 70 Calcium Supplements 70 Lowering Blood Pressure 70 IND Application 70 Cervical Cancer Vaccine 70 Juvenile Idiopathic Arthritis 70 Randomized Clinical Trials 70 First Patient Treated 70 Vaccine Prevents 70 Psychiatric Disorders 70 Limb Ischemia 70 Randomized Phase III 70 Immunotherapeutic 70 Taxane 70 Uterine Fibroids 70 Cyclophosphamide 70 Antiplatelet Therapy 70 Systemic Sclerosis 70 Bipolar Depression 70 Expanded Indication 70 Chronic Renal Failure 70 Carcinoma 70 Prospective Randomized Trial 70 Brain Tumors 70 Randomized Clinical Trial 70 Prevent Fractures 70 Surgical Procedures 70 Acne Drug 70 Tumor Suppressor 70 Rare Genetic 70 Potent Anti 70 Epratuzumab 70 Estrogen Receptor 70 Endometrial 70 Blood Pressure Lowering 70 Bone Marrow Stem Cells 70 Files IND 70 Could Prevent 70 Anticoagulant 70 CYPHER R Sirolimus Eluting 70 Hepatocellular 70 Clinical Trial Data 70 Antipsychotic Drug 70 Genital Herpes 70 Pneumococcal Vaccine 70 Metastatic Breast Cancer 70 Shows Statistically Significant 70 Capsules CII 70 Could Predict 70 Bone Mineral Density 70 Nucleoside 70 Healthbeat Report 70 Bazedoxifene 70 Improves Quality 70 Therapeutic Targets 70 Mg Usa 70 NMDA Receptor 70 Brain Aneurysms 70 Natalizumab 70 Antipsychotic Medications 70 Severe Acne 70 Systematic Review 70 Who Underwent 70 Monoclonal Antibody 70 Novel Compound 70 Vaccine Shows Promise 70 Intracerebral 70 Pertuzumab 70 Stress Urinary Incontinence 70 Acute Migraine 70 Novel Compounds 70 Chronic Myelogenous Leukemia 70 Recurrent Ovarian Cancer 70 Invasive Fungal Infections 70 Smallpox Vaccine 70 Hepatic Encephalopathy 70 Hormonal Therapy 70 Abortion Pill 70 Hospital Acquired Pneumonia 70 Lung Function 70 Respiratory Distress 70 Medoxomil 70 MEK Inhibitor 70 Muscle Function 70 Silicone Breast Implants 70 Mesothelioma Treatment 70 Skin Cells 70 Topical Treatment 70 Vasomotor Symptoms 70 Diagnostic Criteria 70 Complete Remission 70 Demonstrate Significant 70 Treatment Naive HIV 70 Vertebral Fractures 70 Hematopoietic 70 Anti Inflammatory Drug 70 Antifungal 70 HDAC Inhibitor 70 Initiate Phase 70 Radiation Treatment 70 Prostatectomy 70 Sinus Infections 70 Urinary Tract Infections 70 Malignancies 70 Pain Relievers 70 Post Menopausal 70 Aflibercept 70 Breast Cancer Risk 70 MRSA Infections 70 Demonstrates Statistically Significant 70 Survival Rate 70 Myelodysplastic Syndrome 70 Antibiotic Resistant 70 Endovascular Repair 70 Aliskiren 70 Statin Use 70 Malaria Vaccine 70 Kidney Tumors 70 Cancer Vaccines 70 Bare Metal Stent 70 Comorbidities 70 Antiviral Activity 70 Aortic Stenosis 70 Muscle Wasting 69 Adenomas 69 Detect Cancer 69 Vildagliptin 69 Transplant Patient 69 Abdominal Pain 69 Generalized Anxiety Disorder 69 Boceprevir 69 Interferon Alpha 69 Clot Risk 69 Papillary 69 Pregnancy Linked 69 Study Shows Benefits 69 Oral Cavity 69 Clot Busting 69 Lenalidomide 69 Dose Ranging Study 69 Pemetrexed 69 Guidelines Issued 69 Vitamin D Linked 69 Progressive Multifocal Leukoencephalopathy 69 TB Vaccine 69 Peripheral Blood 69 Fulvestrant 69 Sleep Duration 69 Unstable Angina 69 Alemtuzumab 69 Cardiac Resynchronization 69 Potent Antiviral Activity 69 Male Infertility 69 Mortality Risk 69 Pivotal Trials 69 Multicenter Phase 69 B Cell Malignancies 69 Trastuzumab 69 Dialysis Patients 69 Drug Eluting Stents 69 Prevent Prostate Cancer 69 Brain Shrinkage 69 Diagnostic Tests 69 Liver Cirrhosis 69 Tigecycline 69 Antipsychotic 69 Receptor Agonist 69 Prospective Multicenter 69 Visceral Fat 69 Spectrum Pharmaceuticals Announces 69 Phospholipase A2 69 Intravenous Formulation 69 Critical Limb Ischemia 69 Causes Symptoms 69 Phase III Clinical Trials 69 Phase III Pivotal Trial 69 Brain Cells 69 Genes Involved 69 Plaque Psoriasis 69 Smooth Muscle 69 Holds Promise 69 Spinal Fluid 69 JAK2 Inhibitor 69 Lung Cancer Surgery 69 Immunomedics Announces 69 Data Indicate 69 Heterozygous Familial Hypercholesterolemia 69 Successfully Treats 69 First Patient Dosed 69 Posaconazole 69 Melphalan 69 Inflammatory Arthritis